Remission Comes Sooner With Early Tx for SpA (CME/CE)

(MedPage Today) -- Early treatment of active axial spondyloarthritis (SpA) with naproxen plus infliximab (Remicade) led to high rates of remission, which then were sustained whether patients continued to receive naproxen or not after stopping the infliximab, an international research group reported in two studies.
Source: MedPage Today Pain Management - Category: Anesthesiology Source Type: news